Abbvie (ABBV) Stock Analysis [December 2020]

In this video I analyze Abbvie’s (ABBV) stock. Using financial statement analysis, Du Pont analysis, and a discounted cash flow valuation model, I determine whether Abbvie (ABBV) is a good buy or not.

0:00 – Introduction
1:27 – ABBV Balance Sheet and Income Statement
4:39 – ABBV Dupont Analysis
5:53 – ABBV Dividends, Buybacks, and Payout Ratios
8:31 – ABBV Intrinsic Value Estimate
12:06 – ABBV Insider Trading and Conclusion

Liabilities-to-Assets Ratio = Total Liabilities / Total Assets

Current Ratio = Current Assets / Current Liabilities

Quick Ratio = (Current Assets – Inventory) / Current Liabilities

Interest Coverage Ratio = (Earnings before Interest and Taxes) / Income Tax Expense

Payout Ratio = Dividends paid / Net Income

Modified Payout Ratio = (Dividends paid + Share buybacks) / Net Income

FCFE Model Video: https://rumble.com/vbpqun-how-to-value-a-stock-free-cash-flow-to-equity-fcfe-model.html

DuPont Analysis Video: https://rumble.com/vbpq7b-using-dupont-analysis-to-value-firms.html

****** Disclaimer ********
This content is for entertainment and education purposes only. Dr. Dan does not provide investment advice. The information in this video is being presented may not be suitable for all investors as it does not consider individual investor risk tolerance levels, investment goals, or financial circumstances. Past performance may not be a reliable indicator of future performance.